In Focus report: Using multiomics for discovering new drugs
The pharmaceutical industry has changed enormously over time and in more recent years the advancements of technologies that allow a more precise understanding of biological mechanisms has enabled more targeted and precise therapeutics.
Multiomics have been pivotal to this evolvement in the industry, helping teams understand the drivers of disease, discover new biomarkers and develop therapies that target these disease mechanisms.
Download this In Focus report, sponsored by Olink, to learn about how multiomics is changing the drug discovery and development sector, where the investment and support is globally, and the opportunities and challenges for this burgeoning technology.
Learn about:
- The future outlook for multiomics in drug discovery
- The use-cases for mutiomics
- How multiomics is being implemented within neuroscience
